Skip to main content
. 2019 Feb 21;87(3):e00541-18. doi: 10.1128/IAI.00541-18

FIG 2.

FIG 2

At least half of the subjects in each group recognize heterologous antigens. (A) One month after exposure, ≥50% of the subjects showed reactivity to heterologous CSP and MSP. (B) Almost all the heterologous anti-CSP responses after PvCHMI and PfCHMI were IgM. (C) After PfCHMI, similar numbers of subjects had IgM and IgG antibodies directed against PvMSP, while after PvCHMI, higher anti-PvMSP IgM responses were observed.